ibopamine has been researched along with Body Weight in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, R; Brusoni, B; Ghirardi, P; Melloni, GF; Minoja, GM; Scorazzati, G | 1 |
| Colì, L; Mosconi, G; Prandini, R; Stefoni, S | 1 |
| Avanzini, Z; Bellogini, GC; Brusoni, B; Ciampani, N; Dei Cas, L; Gazzola, U; Maggi, GC; Mangiavacchi, M; Metra, M; Pinca, L | 1 |
| Ferrari, V; Marchetti, G; Sher, D | 1 |
2 trial(s) available for ibopamine and Body Weight
| Article | Year |
|---|---|
Renal effect of SB 7505: a double-blind study.
Topics: Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Deoxyepinephrine; Dopamine; Double-Blind Method; Female; Heart Rate; Humans; Kidney; Male; Middle Aged; Placebos | 1981 |
Ibopamine versus hydrochlorothiazide/amiloride in patients with mild congestive heart failure. SK & F Ibopamine Working Group.
Topics: Amiloride; Body Weight; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Drug Combinations; Exercise Test; Female; Heart Failure; Humans; Hydrochlorothiazide; Male; Middle Aged; Vasodilator Agents | 1989 |
3 other study(ies) available for ibopamine and Body Weight
| Article | Year |
|---|---|
Ibopamine (SB 7505) in normal subjects and in chronic renal failure: a preliminary report.
Topics: Adult; Aged; Body Weight; Creatinine; Deoxyepinephrine; Dopamine; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Natriuresis; Potassium | 1981 |
Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
Topics: Adult; Aged; Body Weight; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Dopamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Monitoring, Physiologic; Time Factors | 1986 |
A survey of 311 patients receiving ibopamine mainly during hospital treatment for severe congestive heart failure.
Topics: Age Factors; Aged; Blood Pressure; Body Weight; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Monitoring, Physiologic; Sex Factors | 1986 |